Radiotherapy for cutaneous malignant melanoma: Rationale and indications

ONCOLOGY

Volumn 18, Issue 1, 2004, Pages 99-107

  Ballo, Matthew T ^a   Ang, K Kian ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; LYMPH NODE METASTASIS; MELANOMA; RADIATION DOSE; REVIEW; RISK FACTOR; SKIN TUMOR; SURVIVAL;

HUMANS; LYMPHATIC METASTASIS; MELANOMA; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 2142652941     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Veronesi U, Adamus J, Bandiera DC, et al: Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420-2430, 1982.
2. Cascinelli N, Morabito A, Santinami M, et al: Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial. Lancet 351:793-796, 1998.
3. Balch CM, Soong S Jr, Ross MI, et al: Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7:87-97, 2000.
4. Sím FH, Taylor WF, Pritchard DJ, et al: Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study. Mayo Clin Proc 61:697-705, 1986.
5. Urist MM, Balch CM, Soong S, et al: The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 55:1398-1402, 1985.
6. Ames FC, Balch CM, Reintgen D: Local recurrence and their management, in Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S, (eds): Cutaneous melanoma, pp 287-294. Philadelphia, J.B Lippincott Company, 1992.
7. Roses DF, Harris MN, Rigel D, et al: Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 198:65-69, 1983.
8. Karakousis CP, Balch CM, Urist MM, et al: Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 3:446-452, 1996.
9. Ng AK, Jones WO, Shaw JH: Analysis of local recurrence and optimizing excision margins for cutaneous melanoma. Br J Surg 88:137-142, 2001.
10. Heaton KM, Sussman A Gershenwald JE, et al: Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma. Ann Surg Oncol 5:322-328, 1998.
11. Neades GT, Orr DJ, Hughes LE, et al: Safe margins in the excision of primary cutaneous melanoma. Br J Surg 80:731-733, 1993.
12. Byers RM: The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arch Surg 121:1338-1341, 1986.
13. Loree TR, Spiro RH: Cutaneous melanoma of the head and neck. Am J Surg 158:388-391, 1989.
14. O'Brien CJ, Coates AS, Petersen-Schaefer K, et al: Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 162:310-314, 1991.
15. Fisher SR, O'Brien CJ: Head and neck melanoma, in Balch CM, Houghton AN, Sober AJ, Soong S, (eds): Cutaneous Melanoma, pp 163-174. St Louis, Quality Medical Publishing Inc, 1998.
16. Kelly JW, Sagabiel RW, Calderon W, et al: The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg 200:759-763, 1984.
17. Leon P, Daly JM, Synnestvedt M, et al: The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 126:1461-1468, 1991.
18. Egbert B, Kempson R, Sagebiel R: Desmoplastic malignant melanoma: A clinicohistopathologic study of 25 cases. Cancer 62:2033-2041, 1988.
19. Beenken S, Byers R, Smith JL, et al: Desmoplastic melanoma. Arch Otolaryngol Head Neck Surg 115:374-379, 1989.
20. Smithers BM, McLeod GR, Little JH: Desmoplastic melanoma: Patterns of recurrence. World J Surg 16:186-190, 1992.
21. Calson JA, Dickersin GR, Sober AJ, et al: Desmoplastic neurotropic melanoma: A clinicopathologic analysis of 28 cases. Cancer 75:478-494, 1995.
22. Quinn MJ, Crotty KA, Thompson JF, et al: Desmoplastic and desmoplastic neurotropic melanoma: Experience with 280 patients. Cancer 83:1128-1135, 1998.
23. Payne WG, Kearney R, Wells K, et al: Desmoplastic melanoma. Am Surg 67:1004-1006, 2001.
24. Dickson RJ: Malignant melanoma: a combined surgical and radiotherapeutic approach. Am J Roentgenol 79:1063-1070, 1958.
25. Johanson CR, Harwood AR, Cummings BJ, Quirt I: 0-7-21 radiotherapy in nodular melanoma. Cancer 51:226-232, 1983.
26. Calabro A, Singletary SE, Balch CM: Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 124:1051-1055, 1989.
27. Lee RJ, Gibbs JF, Proulx GM, et al: Nodal basin recurrence following lymph node dissection for melanoma: Implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 46:467-474, 2000.
28. Shen P, Wanek LA, Morton DL: Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas? Ann Surg Oncol 7:554-559, 2000.
29. Monsour PD, Sause WT, Avent JM, et al: Local control following therapeutic nodal dissection for melanoma. J Surg Oncol 54:18-22, 1993.
30. Miller EJ, Synnestvedt M, Schultz D, et al: Loco-regional nodal relapse in melanoma. Surg Oncol 1:333-340, 1992.
31. Bowsher WG, Taylor BA, Hughes LE: Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 73:906-908, 1986.
32. Ballo MT, Strom EA, Zagars GK, et al: Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 52:964-972, 2002.
33. Ballo MT, Bonnen MD, Garden AS, et al: Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 97:1789-1796, 2003.
34. Morris KT, Marquez CM, Holland JM, et al: Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation. Ann Surg Oncol 7:680-684, 2000.
35. Cooper JS, Chang WS, Oratz R, et al: Elective radiation therapy for high-risk malignant melanoma. Cancer J 7:498-502, 2001.
36. O'Brien CJ, Petersen-Schaefer K, Stevens GN, et al: Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 19:589-594, 1997.
37. Corry J, Smith JG, Bishop M, et al: Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 44:1065-1069, 1999.
38. Burmeister BH, Smithers BM, Poulsen M, et al: Radiation therapy for nodal disease in malignant melanoma. World J Surg 19:369-371, 1995.
39. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of malignant melanoma. Arch Surg 130:654-658, 1995.
40. Joseph E, Brobeil A, Glass F, et al: Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 5:119-125, 1998.
41. Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, et al: Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 134:983-987, 1998.
42. Haddad FF, Stall A, Messina J, et al: The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 6:144-149, 1999.
43. Gershenwald JE, Thompson W, Mansfield PF, et al: Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I and II melanoma patients. J Clin Oncol 17:976-983, 1999.
44. Statius Muller MG, Borgstein PJ, Pijpers R, et al: Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 7:461-468, 2000.
45. Bachter D, Michl C, Büchels H, et al: The predictive value of the sentinel lymph node in malignant melanomas. Recent Results Cancer Res 158:129-136, 2001.
46. Blumenthal R, Banic A, Brand CU, et al: Morbidity and outcome after sentinel lymph node dissection in patients with early-stage malignant cutaneous melanoma. Swiss Surg 8:209-214, 2002.
47. Caprio MG, Carbone G, Bracigliano A, et al: Sentinel lymph node detection by lymphoscintigraphy in malignant melanoma. Tumori 88:S43-S45, 2002.
48. Eldh J, Suurkula M, Holmstrom H: Prognosis for localized cutaneous melanoma treated with wide excision only, with special reference to development of regional node metastases. Tumori 73:51-54, 1987.
49. Balch CM: Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol 3:511-524, 1980.
50. Slingluff CL, Stidham KR, Ricci WM, et al: Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg 219:120-130, 1994.
51. Harrist TJ, Rigel DS, Day CL Jr, et al: "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer 53:2183-2187, 1984.
52. Carmichael VE, Robins RE, Wilson KS: Elective and therapeutic regional lymph node dissection for cutaneous malignant melanoma: Experience of the British Columbia Cancer Agency, 1972 to 1981. Can J Surg 35:600-604, 1992.
53. Weissmann A, Roses DF, Harris MN, et al: Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas. Am J Dermatopathol 6(Suppl):35-41, 1984.
54. Fisher SR: Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: Analysis of 1444 patients from 1970 to 1998. Laryngoscope 112:99-110, 2002.
55. Fortner JG, Woodruff J, Schottenfeld D, et al: Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg 186:101-103, 1977.
56. Bonnen MD, Ballo MT, Myers JN, et al: Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer. In press.
57. Sause WT, Cooper JS, Rush S, et al: Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20:429-432, 1991.
58. Ang KK, Peters LJ, Weber RS, et al: Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 30:795-798, 1994.
59. Ballo MT, Ang KK: Radiation therapy for malignant melanoma. Surg Clin North Am 83:323-342, 2003.
60. Urist MM, Maddox WA, Kennedy JE, et al: Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 51:2152-2156, 1983.
61. Burmeister BH, Smithers BM, Davis S, et al: Radiation therapy following nodal surgery for melanoma: An analysis of late toxicity. ANZ J Surg 72:344-349, 2002.
62. Hughes TM, A'Hern RP, Thomas JM: Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 87:892-901, 2000.
63. Karakousis CP, Driscoll DL, Rose B, et al: Groin dissection in malignant melanoma. Ann Surg Oncol 1:271-277, 1994.
64. Kissin MW, Simpson DA, Easton D, et al: Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg 74:1023-1026, 1987.
65. Reeves ME, Delgado R, Busam KJ, et al: Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 10:27-31, 2003.